GlassScriptPhysician profile
April L Blue
NPI 1457350886
$3,896.72
in general payments reported to CMS, 2019-2025
33 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $281 · 2021: $116 · 2022: $563 · 2023: $1,011 · 2024: $1,023 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,484.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $499.10 | 2023-2024 | Interstim |
| Abbvie INC. | $494.18 | 2021-2025 | Vraylar, Ubrelvy, Linzess |
| Novo Nordisk INC | $314.57 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $259.79 | 2019-2025 | Airsupra, Farxiga |
| Abbott Laboratories | $249.27 | 2022-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $229.84 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $225.41 | 2019-2022 | |
| Pfizer INC. | $207.86 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $171.96 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $169.46 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Glaxosmithkline, LLC. | $123.34 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $106.91 | 2019-2022 | |
| Amgen INC. | $104.75 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $96.41 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.86 | 2019-2025 | Xifaxan, Trulance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $74.39 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $61.99 | 2024-2025 | Rexulti |
| Lilly USA, LLC | $58.90 | 2022-2024 | Jardiance |
| Averitas Pharma INC. | $54.69 | 2023-2024 | Qutenza |
| Dexcom, INC. | $41.94 | 2025 | Dexcom G6 Transmitter |
| Currax Pharmaceuticals LLC | $41.35 | 2021-2024 | Contrave |
| Sunovion Pharmaceuticals INC. | $35.33 | 2019-2022 | |
| Corcept Therapeutics | $23.89 | 2025 | Korlym |
| Daiichi Sankyo INC. | $19.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.54 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.93 | 2022 | |
| Inspire Medical Systems, INC. | $18.84 | 2025 | Inspire |
| Electromed, INC. | $18.03 | 2024 | Smartvest |
| E.R. Squibb & Sons, L.L.C. | $16.05 | 2023 | Eliquis |
| Exact Sciences Corporation | $14.17 | 2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $12.46 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.47 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Blue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.